News | July 16, 2021
Jubilant Pharmova’s Roorkee facility placed under import alert
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
The company is doubling its chemistry research capacity that should commission by Q2'FY22
The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.
Jubilant announced the completion of demerger of pharma and LSI business into two separate companies
The company posted net profit of Rs.203.38 crores for the period ended December 31, 2019.
The acquisition will strengthen the overall company’s position as leading global CRO services partner
HSGP is engaged closely with the USFDA and is committed to address the OAI observations through planned remediation measures
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
The Tc 99m Mertiatide Injection is used in the diagnosis of congenital and acquired renal abnormalities
Subscribe To Our Newsletter & Stay Updated
